Patrizia d’Alessio
CEO at AISA Therapeutics, MD PhD, hematologist and cell biologist, expert of the molecular mechanisms of inflammation
Pr. Dr. Patrizia Anna d’Alessio, MD, PhD international expert on biological mechanisms of inflammation, aging and stress.
Training in Medicine & Hematology Milan. PhD Utrecht Universities. Professor of Cell Biology Paris 5 and 11 Universities (1992-2012). Focus on cellular mechanisms of stress-induced premature senescence. Bio-guided study on plant extracts identified small non-toxic anti-inflammatory actives. 2005 French Ministry Research Award Innovative Enterprises. Founder of R&D start-up AISA Therapeutics. Three patents granted in Europe, USA, China. 2009 European FP7 Ristomed project. 2015 AISA Moleculum® trademark - a dietary supplement to relieve stress and signs of inflammation. New book : “Inflammation-body alert system” Dangles ed., launching April 2019.
Visit website: https://www.aisa-tx.com/company/
See also: 
AISA Therapeutics
- Company that develops new anti-inflammatory and anti-senescence molecules
Details last updated 12-May-2023
Patrizia d’Alessio is also referenced in the following:
4th International Conference on Aging and Disease (2023 ICAD)
27-Oct-2023 to 30-Oct-2023
Conference on Aging and Disease organized by International Society on Aging and Disease (ISOAD)
International Future of Health and Technology Summit
10-Oct-2024 to 11-Oct-2024
Unlocking revolutionary health and med-tech vistas for human longevity and well-being - organised by TAFFD's
International Longevity Summit
23-Aug-2023 to 24-Aug-2023
Biotech and Longevity Conference in South Africa organized by TAFFD
Longevity Summit Dublin 2024
13-Jun-2024 to 16-Jun-2024
Event gathering Global Longevity and Rejuvenation community in Dublin by LEV Foundation (Dublin, Ireland)
Potent Anti-Senescence Effects of d-Limonene - Patrizia d’Alessio at Longevity Summit Dublin 2024
Patrizia d’Alessio delivered a keynote on the potent anti-senescence effects of d-Limonene
